Summary
Merck & Co., Inc. (MRK) filed an 8-K report on April 28, 2020, to disclose its first-quarter 2020 financial results. The report incorporates by reference a press release and supplemental information detailing the company's performance during the period. Investors should note that this filing primarily serves to officially furnish these results, as per SEC regulations. The core financial details and operational updates are contained within the attached press release (Exhibit 99.1) and supplemental information (Exhibit 99.2). While the 8-K itself doesn't contain the detailed numbers, it signifies the public release of this crucial earnings data, allowing investors to assess Merck's financial health and operational progress at the start of 2020.
Key Highlights
- 1Merck & Co., Inc. (MRK) announced its first-quarter 2020 financial results on April 28, 2020, via an 8-K filing.
- 2The 8-K filing incorporates by reference a press release (Exhibit 99.1) containing detailed earnings information.
- 3Supplemental financial information not included in the press release is also provided as Exhibit 99.2.
- 4This filing pertains to the reporting of results of operations and financial condition.
- 5The information furnished is not deemed 'filed' for the purposes of Section 18 of the Exchange Act, limiting liability.
- 6The company has common stock and several series of notes listed on the New York Stock Exchange.